Katrina Snow: Non-Invasive Fetal Blood Group Genotyping Is Coming to Ontario
Katrina Snow, Transfusion Safety Officer at North York General Hospital, shared a post on LinkedIn:
“Did you know that up to 40% of RhD-negative pregnancies are with fetuses who are also RhD-negative?
Very soon, non-invasive fetal blood group genotyping will be available in Ontario, which is a non-invasive way to determine the RhD status (and in some cases other red cell antigens) of the fetus.
For patients this means personalized care that can reduce their exposure to a blood product.
For healthcare this means optimization of a limited resource (RhIG).
BORN Ontario will also collect data that will support QI and evaluation.
Provincial wide implementation means there will be equity in access to this testing.
Exciting times!
Stay updated with Hemostasis Today.
-
Sep 9, 2026, 14:30Alejandro González Veliz: 2026 ESC Guidelines Expand Cardiac Rehabilitation Beyond Post-Event Recovery
-
Sep 9, 2026, 13:59Natalie Arnold: Biomarkers and the Hidden Burden of CHD
-
Sep 9, 2026, 13:11Ron DePinho: A Negative Trial Does Not Repudiate Inflammation as a Cardiovascular Target
-
Sep 9, 2026, 13:10Ahmad Gharehbaghian: Visiting the Alborz Provincial Blood Transfusion Center
-
Sep 9, 2026, 13:09Oraianthi Fiste: New Collection on Cancer-Associated Thrombosis From Mechanisms to Precision Medicine
-
Sep 9, 2026, 13:07Can Özlü: Can the HALP Score Help Identify Thrombotic Risk in Myeloproliferative Neoplasms?
-
Sep 9, 2026, 13:06Ohanna Cavalcanti Bezerra: Why Does DVT Lead to PE in Some Patients but Not Others?
-
Sep 9, 2026, 13:04Usman Shehzad: Transforming Patient Lives with INR Self-Testing
-
Sep 9, 2026, 13:02Edward Lee Carter: Provoked VTE May Not Tell the Whole Story About Recurrence Risk